Analysis of influencing factors of steady-state concentration/dose ratio of milnacipran based on therapeutic drug monitoring
1.Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders/National Clinical Research Center for Mental Disorders/National Center for Mental Disorders, Beijing Anding Hospital Afflicated to Capital Medical University, Beijing 100088, China
2.Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development, Beijing 100029, China
收起